Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Midasin AAA ATPase 1 (MDN1) is a massive, essential ATPase enzyme that functions as a nuclear chaperone for the large subunit of the eukaryotic ribosome. MDN1 utilizes ATP hydrolysis to power ATP-fueled motions that physically restructure and remove assembly factors from pre-60S ribosomal particles, a key step in ribosome biogenesis. Structurally, MDN1 contains a ring-shaped AAA ATPase domain, extended linking domains, and a C-terminal MIDAS (Metal Ion-dependent Adhesion Site) domain. The MIDAS domain is responsible for binding substrate proteins (assembly factors), transmitting mechanical force to facilitate their removal via dynamic conformational coupling with the AAA ring. MDN1 is not a druggable target in current pharmacology but is studied via chemical inhibitors like Rbin-1 to dissect ribosome assembly mechanisms. Dysfunction or mutation of MDN1 can disrupt ribosome formation and is implicated in rare human disorders, but it is not an established therapeutic or disease target
Noncompetitive, allosteric inhibition of ATPase activity by Rbin-1 (binds and induces conformational change, affecting the coupling between the AAA ring and the MIDAS domain; used only in research, not a therapeutic mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Midasin AAA ATPase 1 (MDN1).